EVIDENCE PROFILE / PUBLISHED
GHRP-6
GHRP-6 is a synthetic ghrelin-receptor agonist and growth-hormone secretagogue. Small acute human physiology studies show hormone and metabolic responses but do not establish therapeutic benefit.
Evidence at a glance
- Human
- LimitedSmall, short physiology studies measuring hormone responses.
- Animal/cell
- Not rated
- Approved medicine
- None foundScope: the Canadian and U.S. sources reviewed.
Summarises how much research the profile's sources report, and of what kind. It is not a verdict on the compound or on any catalogue material.
PREPPY BOY ASKS
“A familiar name can hide a different molecule, fragment, formulation, or evidence story.”
The catalogue name is a starting point, not proof of formulation or identity. Research examines GH release, appetite-related signaling, glucose and insulin responses, and pituitary physiology.
Identity
GHRP-6 is a synthetic ghrelin-receptor agonist and growth-hormone secretagogue.
Biological mechanism or research interest
Research examines GH release, appetite-related signaling, glucose and insulin responses, and pituitary physiology.
Verified approved human uses
No approved human use was verified in the reviewed Canadian or U.S. sources.
Investigational human evidence
Small acute human physiology studies show hormone and metabolic responses but do not establish therapeutic benefit.
Popular claims versus demonstrated findings
Muscle, recovery, appetite, fat-loss, and anti-aging claims are not demonstrated clinical outcomes.
Human versus animal or cell evidence
Animal and receptor experiments help define ghrelin-system activity but cannot characterize long-term human outcomes.
Limitations and known risks
FDA identifies limited safety information, immunogenicity concerns, cortisol effects, and possible increased blood glucose through reduced insulin sensitivity.
